Search CDMOs

• CMC Analytical Development
• API Synthesis & Manufacturing
• Biologics Development & Manufacturing

Patheon is a trusted global contract development and manufacturing organization (CDMO) partner owned by Thermo Fisher Scientific, offering 360° integrated solutions from early-stage R&D through clinical supply and commercial manufacturing.

• ADC (Antibody-Drug Conjugate) Manufacturing
• ADC Payload & Linker Synthesis
• CMC Analytical Development

Leading CDMO offering end-to-end biologics development and manufacturing from cell line development through aseptic fill-finish, with capabilities in drug substance, drug product, ADC, and mRNA services.

• AAV Manufacturing
• CMC Analytical Development
• API Synthesis & Manufacturing

Leading global CDMO offering end-to-end development and manufacturing for pharma, biotech, and consumer health—spanning oral dose, biologics, cell and gene therapies, clinical supply, and specialty formulations with advanced technologies and worldwide GMP capacity.

• CMC Analytical Development
• API Synthesis & Manufacturing
• Biologics Development & Manufacturing

Integrated global pharmaceutical company manufacturing generics, APIs, biosimilars, and innovative medicines across 66 countries with capabilities in small molecule and biologics development and manufacturing.

• CMC Analytical Development
• CMC Regulatory Submission Support
• Cold-Chain Storage & Logistics

Comprehensive sterile fill-finish and lyophilization CDMO with decades of experience, advanced automation, and white-glove service for global pharmaceutical partners.

• AAV Manufacturing
• ADC (Antibody-Drug Conjugate) Manufacturing
• ADC Payload & Linker Synthesis

Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.

• AAV Manufacturing
• ADC (Antibody-Drug Conjugate) Manufacturing
• ADC Payload & Linker Synthesis

Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.

• API Synthesis & Manufacturing
• Sterile Fill-Finish & Aseptic Manufacturing
• Formulation Development

U.S.-based biopharmaceutical company offering oral solid dosage, injectables, and API manufacturing with FDA-approved facilities across the U.S. and India, including advanced capabilities in lyophilization, aseptic processing, and oncology formulations.

• CMC Analytical Development
• Cartridge Filling
• CMC Regulatory Submission Support

US-based aseptic fill-finish CDMO specializing in parenteral biologics, peptides, and small molecules from development through commercial supply, with formulation, analytical, stability testing, and vial/syringe/cartridge filling capabilities.

• CMC Analytical Development
• API Synthesis & Manufacturing
• CMC Regulatory Submission Support

India's largest CDMO with 15+ state-of-the-art facilities and 30% domestic market share, manufacturing 4,100+ formulations across tablets, capsules, injectables, APIs, and specialty dosage forms under WHO-GMP, USFDA, EU-GMP, and TGA compliance.

• CMC Analytical Development
• CMC Regulatory Submission Support
• Sterile Fill-Finish & Aseptic Manufacturing

Ascendia is a specialty CDMO offering formulation development, analytical services, and cGMP manufacturing for small molecules, biologics, and gene delivery therapies, with proprietary nanotechnologies for solubility and bioavailability enhancement.